NBA to host preseason games in China five years after league was effectively blocked from the countryEllington Credit ( NYSE:EARN – Get Free Report ) declared a monthly dividend on Friday, December 6th, NASDAQ Dividends reports. Shareholders of record on Tuesday, December 31st will be given a dividend of 0.08 per share by the real estate investment trust on Monday, January 27th. This represents a $0.96 annualized dividend and a yield of 14.44%. The ex-dividend date is Tuesday, December 31st. Ellington Credit has increased its dividend payment by an average of 39.3% per year over the last three years. Ellington Credit has a dividend payout ratio of 84.2% indicating that its dividend is currently covered by earnings, but may not be in the future if the company’s earnings tumble. Research analysts expect Ellington Credit to earn $1.13 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 85.0%. Ellington Credit Trading Up 0.3 % Shares of Ellington Credit stock opened at $6.65 on Friday. The company has a market cap of $194.03 million, a PE ratio of 5.94 and a beta of 1.86. The company has a 50 day moving average of $6.67 and a 200-day moving average of $6.84. Ellington Credit has a 1-year low of $5.54 and a 1-year high of $7.26. Wall Street Analysts Forecast Growth Separately, StockNews.com upgraded Ellington Credit from a “sell” rating to a “hold” rating in a research report on Wednesday, November 20th. Check Out Our Latest Stock Report on Ellington Credit Ellington Credit Company Profile ( Get Free Report ) Ellington Credit Company, a real estate investment trust, acquires, invests in, and manages residential mortgage-and real estate-related assets. It acquires and manages residential mortgage-backed securities (RMBS), including agency pools and agency collateralized mortgage obligations (CMOs); and non-agency RMBS, such as non-agency CMOs, such as investment grade and non-investment grade. Featured Stories Receive News & Ratings for Ellington Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ellington Credit and related companies with MarketBeat.com's FREE daily email newsletter .
RLJ Lodging Trust ( NYSE:RLJ – Get Free Report ) declared a quarterly dividend on Friday, December 13th, RTT News reports. Investors of record on Tuesday, December 31st will be paid a dividend of 0.15 per share by the real estate investment trust on Wednesday, January 15th. This represents a $0.60 annualized dividend and a dividend yield of 5.91%. The ex-dividend date is Tuesday, December 31st. RLJ Lodging Trust has a dividend payout ratio of 315.8% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect RLJ Lodging Trust to earn $1.42 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 42.3%. RLJ Lodging Trust Stock Performance Shares of RLJ opened at $10.15 on Friday. The company has a 50-day simple moving average of $9.85 and a two-hundred day simple moving average of $9.54. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.74 and a quick ratio of 2.74. The firm has a market capitalization of $1.56 billion, a PE ratio of 35.00, a price-to-earnings-growth ratio of 2.31 and a beta of 1.72. RLJ Lodging Trust has a one year low of $8.74 and a one year high of $12.39. Analyst Ratings Changes A number of brokerages have recently commented on RLJ. Oppenheimer boosted their target price on shares of RLJ Lodging Trust from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. StockNews.com raised shares of RLJ Lodging Trust from a “sell” rating to a “hold” rating in a research note on Friday, December 6th. Wolfe Research downgraded shares of RLJ Lodging Trust from an “outperform” rating to a “peer perform” rating in a research note on Thursday, September 26th. Wells Fargo & Company lifted their target price on shares of RLJ Lodging Trust from $10.00 to $10.50 and gave the company an “underweight” rating in a report on Monday, December 9th. Finally, Truist Financial cut their price target on RLJ Lodging Trust from $14.00 to $11.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $11.50. Get Our Latest Analysis on RLJ Lodging Trust RLJ Lodging Trust Company Profile ( Get Free Report ) RLJ Lodging Trust is a self-advised, publicly traded real estate investment trust that owns primarily premium-branded, high-margin, focused-service and compact full-service hotels. The Company's portfolio currently consists of 96 hotels with approximately 21,200 rooms, located in 23 states and the District of Columbia and an ownership interest in one unconsolidated hotel with 171 rooms. Further Reading Receive News & Ratings for RLJ Lodging Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLJ Lodging Trust and related companies with MarketBeat.com's FREE daily email newsletter .Who was Rosalynn Carter? All about President Jimmy Carter's wife of 77 years
Sam Hicks, defense lead Abilene Christian over Northern Arizona 24-0 to extend 1st trip to playoffs
Michael Moore warned Democrats that the party’s continued support of supplying arms to Israel could cost them “more elections.” “What better way to celebrate losing the November 5th election than by continuing to ignore the will of the American people who oppose Israel’s war on Gaza,” the filmmaker wrote in a Substack post on Saturday. “Gaza. Nothing says to the public ‘we hear you’ better than the Democratic Party announcing that ‘we’re going to kill even more children in Palestine now with your/our American tax dollars.’” Moore’s scathing critique of his own political party comes following more than a 30 Democratic senators voting against resolutions this week that would have blocked arms being sent to Israel . The PEACE resolution was introduced by Vermont Sen. Bernie Sanders and aimed to narrow the scope of US support in Israel’s war efforts in Gaza. ADVERTISEMENT Moore dubbed the Democratic lawmakers who opposed the resolution, including Pennsylvania’s Sen. John Fetterman and New Jersey Sen. Cory Booker , “genocide arms dealers.” Those who voted in support, he commended for having “the courage to say no.” “Democratic senators should know better. And their behavior in supporting this aggression will only cost them more elections,” Moore wrote. “Voters under 45 and people of color combined (making up nearly half the electorate), have no interest in war and would rather our government spend our money on our schools, our elderly, and our broken health care system. Time to cut Bibi off.” A longtime critic of Democrats' support of Israel, Moore helped organize an effort that led to 100,000 people in Michigan casting protest votes against President Joe Biden in the state primary. Ahead of the 2024 presidential election, he urged Kamala Harris to use her leverage as vice president to demand that Biden broker a cease-fire and withhold military aid from Israel.
Another Good Reason to Hate the Church: Exploring the Religious-Political Merging of the Abortion Chasm.
Colorado Springs area literary events starting Dec. 29Obie Okoye: Empowering Communities through technology, innovation
Fairfield and Vacaville police several other law enforcement agencies from across the county to arrest 28 civilian protesters at Travis Air Force Base on Thursday morning. At about 6:30 a.m., approximately 50 protesters arrived at Travis Air Force Base to protest what the department described as “issues in the Middle East.” Protesters indicated they were there to protest U.S. involvement in the conflict in Gaza, according to multiple news outlets. The group is protesting the U.S. supply of weapons to the region. “Participants were advised that, while peaceful protests were entirely within the exercise of their constitutional rights, they could not block the roadway,” the department said. “Several protestors ignored this instruction, spilling out into the road and intentionally blocking access to the base.” Six citizens were arrested at the south gate, 20 were arrested at the main gate and two were arrested at the north gate. Deputies from the Sheriff’s Department were also involved with arrests.
Austin, Dec. 08, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “ The Downstream Processing Market was valued at USD 29.35 Billion in 2023 and is projected to reach USD 99.64 Billion by 2032, growing at a compound annual growth rate (CAGR) of 14.60% from 2024 to 2032. ” Accelerating Growth of the Downstream Processing Market The downstream processing market is experiencing rapid expansion, fueled by the surging demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and enzymes. This growth is driven by the rising prevalence of chronic diseases and advancements in biotechnology, which have spurred the development of biologics. With global pharmaceutical industry revenues reaching approximately USD 1.6 trillion in 2023, biopharmaceuticals have emerged as a significant and fast-growing segment. Downstream processing is pivotal in ensuring the efficient purification and recovery of these complex products, promoting further innovation in the field. This innovation is reflected in the adoption of advanced technologies like single-use systems, membrane chromatography, and continuous processing. By Q1 2023, over 100 approved gene, cell, and RNA therapies, alongside 3,700 therapies in development, underscored the rising need for scalable solutions. These advancements enhance operational efficiency, reduce costs, and support the increasing global demand for biologics. Download PDF Sample of Downstream Processing Market @ https://www.snsinsider.com/sample-request/2618 Key Players: Merck KGaA (MilliporeSigma) (Viresolve Barrier Filters, ProSep Ultra Plus Protein A Resin) Sartorius Stedim Biotech S.A (Sartobind Membrane Adsorbers, Sartoflow Advanced Systems) Thermo Fisher Scientific Inc. (POROS Chromatography Resins, CaptureSelect Affinity Ligands) Danaher Corporation (Pall Allegro MVP Single-Use System, Cytiva ReadyToProcess Columns) Repligen (OPUS Pre-packed Columns, XCell ATF Systems) 3M Company (Zeta Plus Depth Filters, Emphaze AEX Hybrid Purifiers) Boehringer Ingelheim International GmbH (BIHEX Process Solutions, Biopharmaceutical Contract Services) Corning Corporation (Corning CellCube Systems, X-Series Hollow Fiber Filters) Lonza Group Ltd (Centrifuge Systems, Viral Clearance Services) Dover Corporation (Quattroflow Diaphragm Pumps, Maag Industrial Filtration Solutions) Asahi Kasei (Planova Virus Filters, Microza UF Membranes) Eppendorf AG (Centrifuge 5910 R, BioFlo Bioprocess Controllers) Finesse Solutions Inc. (Thermo Fisher Subsidiary) (SmartVessel Bioreactor, G3Lab Universal Controllers) Purolite Life Sciences (Praesto Protein A Resins, Chromalite Ion Exchange Resins) Tosoh Bioscience (TOYOPEARL Protein A Resins, TSKgel Chromatography Columns) Novasep (BioSC Chromatography Systems, Prochrom Bio Columns) MilliporeSigma (a subsidiary of Merck KGaA) (Durapore Filters, Chromabolt Pre-packed Columns) Waters Corporation (PATROL UPLC Process Analyzer, AutoPurification Systems) PerkinElmer Inc. (LabChip GXII Microfluidics System, QSight 420 Mass Spectrometer) Bio-Rad Laboratories, Inc. (UNOsphere Chromatography Resins, NGC Chromatography Systems) Avantor (VWR) (J.T.Baker High Purity Solvents, Arium Sterile Filtration Units) Spectrum Labs (Repligen subsidiary) (KrosFlo TFF Systems, Hollow Fiber TFF Modules) Meissner Filtration Products (UltraCap Depth Filters, FlexGro Single-Use Assemblies) Downstream Processing Market Report Scope: If You Need Any Customization on Downstream Processing Market Report, I nquire Now @ https://www.snsinsider.com/enquiry/2618 By Application , Antibiotics Dominate While Antibodies Drive Rapid Growth in Downstream Processing Market In 2023, the Antibiotic Production segment captured 34% of the downstream processing market revenue, driven by global demand to combat bacterial infections. Their widespread application in healthcare and agriculture, coupled with mature manufacturing practices, ensures large-scale production and steady revenues. Cost-effective purification methods and antibiotics' essential role in public health further solidify this segment's dominance. The Antibodies Production segment is expected to grow at a CAGR of 16.51% from 2024 to 2032, fueled by rising demand for monoclonal antibodies and biosimilars to treat cancer and autoimmune diseases. Innovations in scalable downstream technologies, such as chromatography and single-use systems, and a robust pipeline of therapies are accelerating growth, highlighting the segment’s expanding prominence in biopharma. By Technique , Chromatography Leads While Solid-Liquid Separation Drives Future Growth In 2023, the Purification By Chromatography segment accounted for 42% of the downstream processing market revenue, owing to its unmatched ability to deliver high-purity biomolecules. Its adaptability for diverse biopharmaceuticals, including monoclonal antibodies and vaccines, has positioned it as a vital industry tool. Ongoing technological advancements have further solidified its role as the most reliable purification method. The Solid-Liquid Separation segment is poised to grow at the fastest CAGR of 16.99% from 2024 to 2032, driven by rising demand for efficient filtration and centrifugation solutions. Its critical role in biologics and cell therapy production, coupled with a shift toward sustainable and cost-effective manufacturing, drives innovation. These factors underline its importance in meeting the evolving needs of the biopharma sector. North America Dominates, Asia Pacific Drives Rapid Growth In 2023, North America accounted for 36% of the downstream processing market revenue, led by its strong biopharmaceutical industry and advanced R&D infrastructure. Substantial investments in manufacturing technologies and the presence of major market players have reinforced its dominance. High demand for biologics and favorable regulatory support further cement its leadership. The Asia Pacific region is set to grow at the fastest CAGR of 16.68% from 2024 to 2032, driven by increasing biopharma investments and expanding healthcare infrastructure. Government initiatives promoting local biomanufacturing and cost-efficient production capabilities are key growth drivers. The region's rising demand for biologics and biosimilars underscores its growing role in the global market. Buy Full Research Report on Downstream Processing Market 2024-2032 @ https://www.snsinsider.com/checkout/2618 Key Developments in the Downstream Processing Market On November 21, 2024, Sartorius Stedim Biotech inaugurated its Center for Bioprocess Innovation in Marlborough, USA, focusing on cell and gene therapy manufacturing with GMP suites set to open in 2025. On November 7, 2024, Thermo Fisher Scientific announced the construction of a 10,000-square-foot Bioprocess Design Center in Hyderabad, India, to advance biotherapeutics manufacturing, opening in early 2025. Table of Contents – Major Key Points 1. Introduction Market Definition Scope (Inclusion and Exclusions) Research Assumptions 2. Executive Summary Market Overview Regional Synopsis Competitive Summary 3. Research Methodology Top-Down Approach Bottom-up Approach Data Validation Primary Interviews 4. Market Dynamics Impact Analysis Market Driving Factors Analysis PESTLE Analysis Porter’s Five Forces Model 5. Statistical Insights and Trends Reporting Regulatory Approvals Technological Adoption Rates Cost Contributions Regulatory Approvals 6. Competitive Landscape List of Major Companies, By Region Market Share Analysis, By Region Product Benchmarking Strategic Initiatives Technological Advancements Market Positioning and Branding 7. Downstream Processing Market Segmentation, by Application 8. Downstream Processing Market Segmentation, by Product 9. Downstream Processing Market Segmentation, by Technique 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion Speak with O ur E xpert A nalyst T oday to G ain D eeper I nsights @ https://www.snsinsider.com/request-analyst/2618 [For more information or need any customization research mail us at info@snsinsider.com ] About Us: S&S Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.As Namibia inches closer to the presidential and National Assembly elections, a unique event promises to bring a fresh perspective to the national discourse.The Windhoek Comedy Fes ... If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.